Trending News
News
News
A*Star Scientists Lead the Way in Deciphering the H1N1 Virus Structural Code
New 3D structural model of critical viral protein presents timely molecular information on the fast evolving H1N1 virus.
News
GlaxoSmithKline Accelerates Research with BioTrove's RapidFire® System at Two Key U.S. R&D Sites
High-throughput mass spectrometry technology to provide Research Triangle Park and Upper Providence with drug discovery and in vitro ADME Data.
News
Lorus Announces a Cooperative Research and Development Agreement with National Cancer Institute
Preclinical evaluation of Lorus' RNA-targeted drugs as part of a novel therapeutic strategy for Renal Cell Carcinomas.
News
Intradigm Announces Issuance of RNA Interference Patent Covering Potent Sirna Sequence
First patent to be issued from among Intradigm’s large collection of pending siRNA sequence patents.
News
MDRNA’s RNAi-Based Compounds Demonstrate High Potency Against Multiple Targets in Preclinical Studies
The positive in vivo efficacy data show that UsiRNA constructs are highly potent and highly specific against ApoB and Factor VII message.
News
RXi Pharmaceuticals Presented Breakthrough RNAi Delivery Technologies at the TIDES® 2009 Conference
Company’s CSO, Anastasia Khvorova, presented new pre-clinical data on therapeutically advanced RNAi compounds and delivery technologies.
News
Oxford Gene Technology Successfully Completes World’s Largest Copy Number Variation Study
The project analyzed DNA samples from 20,000 samples to identify genetic variants that play a role in various human diseases.
News
Professors Sir David and Birgit Lane to Resume Full-Time Appointments in Singapore
David Lane and Birgit Lane are to take up full-time appointments with the Agency for Science, Technology and Research in Singapore from 1st September 2009.
News
Revealing the Long-Awaited Atomic Structure of a Well-Known Enzyme
Boston University researchers identify the structural underpinnings of a widely-known enzyme - acetoacetate decarboxylase.
News
Link Technologies Inks Exclusive License to Agilent Technologies’ TC RNA Monomers
Link to manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.
Advertisement